Sulfoxides

Medchemexpress LLC 1-(2-(dimethylamino)ethyl)-3-(7-methylbenzo[1,2-d:3,4-d']bis(thiazole)-2-yl)urea | 1428729-63-8 | MFCD31619259 | 99.5% | 335.45 | C14H17N5OS2 | 100 MG

Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More

RIG-1 modulator 1 is a small-molecule antiviral research compound described as "Compound of claim 13" that modulates RIG-1-related activity and is reported active against influenza virus, HBV, HCV, and HIV. It is supplied as a characterized solid for in vitro research and includes storage and stability information for powder and solutions.

• High purity: 99.5%.
• Appearance: solid, white to light yellow.
• Molecular formula: C14H17N5OS2; molecular weight: 335.45.
• Available in multiple pack sizes, including 100 mg.
• Storage recommendations: powder -20 °C (up to 3 years) or 4 °C (up to 2 years); in solvent -80 °C (up to 2 years).
• Intended for research use only; not for human or clinical use.

Medchemexpress LLC 1-(2-(dimethylamino)ethyl)-3-(7-methylbenzo[1,2-d:3,4-d']bis(thiazole)-2-yl)urea | 1428729-63-8 | MFCD31619259 | 99.5% | 335.45 | C14H17N5OS2 | 10 MG

Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More

RIG-1 modulator 1 is a small-molecule research compound described as an antiviral agent with reported activity against influenza virus, hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV). It is supplied as a solid for laboratory research; key analytical data include molecular formula C14H17N5OS2 and molecular weight 335.45 g/mol.

Medchemexpress LLC 1-(2-(dimethylamino)ethyl)-3-(7-methylbenzo[1,2-d:3,4-d']bis(thiazole)-2-yl)urea | 1428729-63-8 | MFCD31619259 | 99.5% | 335.45 g/mol | C14H17N5OS2 | 25 MG

Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More

RIG-1 modulator 1 is a small-molecule antiviral research compound reported to modulate the RIG-1 pathway and to have activity against influenza virus, hepatitis B virus (HBV), hepatitis C virus (HCV), and HIV. The product is supplied as a solid (white to light yellow) for research use and is accompanied by supporting documentation such as a certificate of analysis and safety data sheet.

• Small-molecule RIG-1 pathway modulator.
• Reported activity against influenza, HBV, HCV, and HIV.
• High reported purity suitable for research applications.
• Supplied as a solid with documented appearance and handling information.
• Available with COA and SDS for quality and safety verification.